At insitro, we are combining human biology at scale and machine learning to discover and develop new therapeutics. The heart of our strategy is to produce large data sets that will drive machine learning and yield key biological insights. This strategy requires a seamless, robust, and effective operation that simultaneously spans internal and partnered projects.
Reporting to the Head of Financials Operations, we are seeking an experienced, hands-on, detail-oriented and customer service oriented payroll and stock administration professional to join our growing team. As the first hire in this role, you will be accountable for all payroll and stock administration activities, including and not limited to: evaluating and implementing a new payroll system, processing payroll twice a month for exempt and nonexempt employees, ensuring timely filing of all quarterly and annual tax forms, recording all payroll activity in the general ledger, maintaining timely and accurate stock administration transactions, and reviewing and approving employee expense reports. The successful candidate will partner with the Accounting & Finance Team and regularly interact with HR while supporting all departments in the Company. Further, you will help implement “best in class” payroll policies and tools to streamline and support our rapid company growth.
Your primary duties will be:
You will be joining an exciting biotech startup that has long-term stability due to significant funding, yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact across several functions and disciplines. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us in leading the way to better medicines through predictive models by integrating machine learning and biology at scale.
Benefits at insitro
insitro is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern machine learning methods to be brought to bear on key bottlenecks in pharmaceutical R&D. The resulting predictive models are used to accelerate target selection, to design and develop effective therapeutics, and to inform clinical strategy. insitro was launched in 2018 with a Series A of $100M funded by top investors including a16z, Arch Venture Partners, Foresite Capital, GV, and Third Rock Ventures.
The company has announced collaborations with Gilead Sciences in the area of NASH (2019) and Bristol Myers Squibb in the area of ALS (2020) and, in mid 2020, completed a Series B financing of $143M including current investors and new investors Canada Pension Plan Investment Board (CPP Investments), T. Rowe Price, BlackRock, Casdin Capital and other leading investors. The company is located in South San Francisco, CA. For more information about insitro, please visit the company’s website at www.insitro.com
Your application was submitted successfully.